Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CR-4056 by Rottapharm Biotech for Osteoarthritis Pain: Likelihood of Approval
CR-4056 is under clinical development by Rottapharm Biotech and currently in Phase II for Osteoarthritis Pain. According to GlobalData, Phase...
Data Insights
CR-6086 by Rottapharm Biotech for Metastatic Colorectal Cancer: Likelihood of Approval
CR-6086 is under clinical development by Rottapharm Biotech and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData,...